VANCOUVER, British Columbia, Sept. 07, 2022 (GLOBE NEWSWIRE) — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a Canadian-based company licensed by Health Canada to produce natural, scalable, and accessible psychedelic and functional mushroom products for transformational human experiences, is pleased to announce that it has entered into an agreement with…


Previous articleMindMed to Participate in H.C. Wainwright Global Investment ConferenceUSA – EnglishUSA – EnglishUSA – English
Next articleMindset Pharma Files National Patents Protecting Family 1 Application in 16 Different Countries